Sammy Bell, Ph.D.

Adjunct Professor

Sammy Bell, Ph.D.

Sr. Director, External Alternative CMC, Boehringer Ingelheim

  • Ph.D., Chemistry / Pharmacology, University of Rhode Island, 2017
  • M.S., Chemistry, University of Rhode Island, 2007
  • B.S., Chemistry, University of Connecticut, 2002
Other Professional Experience
  • Boehringer Ingelheim Animal Health (Merial), Duluth, Georgia (Aug 2016 – Present)
  • Alcon Laboratories (Novartis), Johns Creek, Georgia (Nov 2012 – Aug 2016)
  • Pfizer Global Research and Development, Groton Connecticut (2002 – 2012)
Areas of Expertise
  • Process chemistry experience from R&D through late stage manufacturing
  • Pharmaceutical Scientist with expertise from pre-formulation to late stage formulation development (Ph I/II/III) of parenteral and solid oral dosage forms
  • Discovery Chemistry / Research Formulations / Oral Controlled Release / Product Enhancement
  • Drug Delivery and Drug Product Development / Manufacture

Join a cutting-edge engineering program at a time-honored university

Apply Today Make A Gift